Search Results - "Aluicio‐Sarduy, Eduardo"

Amplification of Cerenkov Luminescence Using Semiconducting Polymers for Cancer Theranostics by Rosenkrans, Zachary T., Hsu, Jessica C., Aluicio‐Sarduy, Eduardo, Barnhart, Todd E., Engle, Jonathan W., Cai, Weibo

“…The therapeutic efficacy of photodynamic therapy is limited by the ability of light to penetrate tissues. Due to this limitation, Cerenkov luminescence (CL)…”
Get full text

Establishing Radiolanthanum Chemistry for Targeted Nuclear Medicine Applications by Aluicio‐Sarduy, Eduardo, Thiele, Nikki A., Martin, Kirsten E., Vaughn, Brett A., Devaraj, Justin, Olson, Aeli P., Barnhart, Todd E., Wilson, Justin J., Boros, Eszter, Engle, Jonathan W.

“…We report the first targeted nuclear medicine application of the lanthanum radionuclides 132/135La. These isotopes represent a matched pair for diagnosis via…”
Get full text

Construction of the Bioconjugate Py‐Macrodipa‐PSMA and Its In Vivo Investigations with Large 132/135La3+ and Small 47Sc3+ Radiometal Ions by Hu, Aohan, Martin, Kirsten E., Śmiłowicz, Dariusz, Aluicio‐Sarduy, Eduardo, Cingoranelli, Shelbie J., Lapi, Suzanne E., Engle, Jonathan W., Boros, Eszter, Wilson, Justin J.

“…To harness radiometals in clinical settings, a chelator forming a stable complex with the metal of interest and targets the desired pathological site is…”
Get full text

“Off‐Label Use” of the Siderophore Enterobactin Enables Targeted Imaging of Cancer with Radioactive Ti(IV) by Koller, Angus J., Glaser, Owen, DeLuca, Molly C., Motz, Rachel N., Amason, Edith K., Carbo‐Bague, Imma, Mixdorf, Jason C., Guzei, Ilia A., Aluicio‐Sarduy, Eduardo, Śmiłowicz, Dariusz, Barnhart, Todd E., Ramogida, Caterina F., Nolan, Elizabeth M., Engle, Jonathan W., Boros, Eszter

“…The development of inert, biocompatible chelation methods is required to harness the emerging positron emitting radionuclide 45Ti for radiopharmaceutical…”
Get full text

PET radiometals for antibody labeling by Aluicio‐Sarduy, Eduardo, Ellison, Paul A., Barnhart, Todd E., Cai, Weibo, Nickles, Robert Jerry, Engle, Jonathan W.

“…Recent advances in molecular characterization of tumors have made possible the emergence of new types of cancer therapies where traditional cytotoxic drugs and…”
Get full text

Electric field induced structural colour tuning of a silver/titanium dioxide nanoparticle one-dimensional photonic crystal by Aluicio-Sarduy, Eduardo, Callegari, Simone, Figueroa Del Valle, Diana Gisell, Desii, Andrea, Kriegel, Ilka, Scotognella, Francesco

“…An electric field is employed for the active tuning of the structural colour in photonic crystals, which acts as an effective external stimulus with an impact…”
Get full text

All Solution-Processed, Hybrid Organic–Inorganic Photocathode for Hydrogen Evolution by Rojas, Hansel Comas, Bellani, Sebastiano, Sarduy, Eduardo Aluicio, Fumagalli, Francesco, Mayer, Matthew T, Schreier, Marcel, Grätzel, Michael, Di Fonzo, Fabio, Antognazza, Maria Rosa

“…Nowadays, the efficient, stable, and scalable conversion of solar energy into chemical fuels represents a great scientific, economic, and ethical challenge…”
Get full text

Low-dose targeted radionuclide therapy renders immunologically cold tumors responsive to immune checkpoint blockade by Patel, Ravi B, Hernandez, Reinier, Carlson, Peter, Grudzinski, Joseph, Bates, Amber M, Jagodinsky, Justin C, Erbe, Amy, Marsh, Ian R, Arthur, Ian, Aluicio-Sarduy, Eduardo, Sriramaneni, Raghava N, Jin, Won Jong, Massey, Christopher, Rakhmilevich, Alexander L, Vail, David, Engle, Johnathan W, Le, Trang, Kim, KyungMann, Bednarz, Bryan, Sondel, Paul M, Weichert, Jamey, Morris, Zachary S

“…Molecular and cellular effects of radiotherapy on tumor microenvironment (TME) can help prime and propagate antitumor immunity. We hypothesized that delivering…”
Get more information

Py-Macrodipa: A Janus Chelator Capable of Binding Medicinally Relevant Rare-Earth Radiometals of Disparate Sizes by Hu, Aohan, Aluicio-Sarduy, Eduardo, Brown, Victoria, MacMillan, Samantha N, Becker, Kaelyn V, Barnhart, Todd E, Radchenko, Valery, Ramogida, Caterina F, Engle, Jonathan W, Wilson, Justin J

“…Nuclear medicine leverages different types of radiometals for disease diagnosis and treatment, but these applications usually require them to be stably…”
Get full text

Controlling the Redox Chemistry of Cobalt Radiopharmaceuticals by Lin, Wilson, Śmiłowicz, Dariusz, Joaqui-Joaqui, M Andrey, Bera, Abhijit, Zhong, Zhuoran, Aluicio-Sarduy, Eduardo, Mixdorf, Jason C, Barnhart, Todd E, Engle, Jonathan W, Boros, Eszter

“…The elementally matched 55Co (t1/2 = 17.53 h, Iβ+ = 77%)/58mCo (t1/2 = 9.10 h, IC= 100%) radioisotope pair is of interest for development of paired…”
Get full text

Construction of the Bioconjugate Py-Macrodipa-PSMA and Its In Vivo Investigations with Large 132/135 La 3+ and Small 47 Sc 3+ Radiometal Ions by Hu, Aohan, Martin, Kirsten E, Śmiłowicz, Dariusz, Aluicio-Sarduy, Eduardo, Cingoranelli, Shelbie J, Lapi, Suzanne E, Engle, Jonathan W, Boros, Eszter, Wilson, Justin J

“…To harness radiometals in clinical settings, a chelator forming a stable complex with the metal of interest and targets the desired pathological site is…”
Get full text

[nat/44Sc(pypa)]−: Thermodynamic Stability, Radiolabeling, and Biodistribution of a Prostate-Specific-Membrane-Antigen-Targeting Conjugate by Li, Lily, Jaraquemada-Peláez, María de Guadalupe, Aluicio-Sarduy, Eduardo, Wang, Xiaozhu, Jiang, Dawei, Sakheie, Meelad, Kuo, Hsiou-Ting, Barnhart, Todd E, Cai, Weibo, Radchenko, Valery, Schaffer, Paul, Lin, Kuo-Shyan, Engle, Jonathan W, Bénard, François, Orvig, Chris

“…44Sc is an attractive positron-emitting radionuclide for PET imaging; herein, a new complex of the Sc3+ ion with nonmacrocyclic chelator H4pypa was synthesized…”
Get full text

Safety and feasibility of an in situ vaccination and immunomodulatory targeted radionuclide combination immuno-radiotherapy approach in a comparative (companion dog) setting by Magee, Kara, Marsh, Ian R, Turek, Michelle M, Grudzinski, Joseph, Aluicio-Sarduy, Eduardo, Engle, Jonathan W, Kurzman, Ilene D, Zuleger, Cindy L, Oseid, Elizabeth A, Jaskowiak, Christine, Albertini, Mark R, Esbona, Karla, Bednarz, Bryan, Sondel, Paul M, Weichert, Jamey P, Morris, Zachary S, Hernandez, Reinier, Vail, David M

“…Murine syngeneic tumor models have revealed efficacious systemic antitumor responses following primary tumor in situ vaccination combined with targeted…”
Get full text

A High Separation Factor for 165Er from Ho for Targeted Radionuclide Therapy by Da Silva, Isidro, Johnson, Taylor R., Mixdorf, Jason C., Aluicio-Sarduy, Eduardo, Barnhart, Todd E., Nickles, R. Jerome, Engle, Jonathan W., Ellison, Paul A.

“…Background: Radionuclides emitting Auger electrons (AEs) with low (0.02–50 keV) energy, short (0.0007–40 µm) range, and high (1–10 keV/µm) linear energy…”
Get full text

Temporal analysis of type 1 interferon activation in tumor cells following external beam radiotherapy or targeted radionuclide therapy by Jagodinsky, Justin C, Jin, Won Jong, Bates, Amber M, Hernandez, Reinier, Grudzinski, Joseph J, Marsh, Ian R, Chakravarty, Ishan, Arthur, Ian S, Zangl, Luke M, Brown, Ryan J, Nystuen, Erin J, Emma, Sarah E, Kerr, Caroline, Carlson, Peter M, Sriramaneni, Raghava N, Engle, Jonathan W, Aluicio-Sarduy, Eduardo, Barnhart, Todd E, Le, Trang, Kim, KyungMann, Bednarz, Bryan P, Weichert, Jamey P, Patel, Ravi B, Morris, Zachary S

“…Clinical interest in combining targeted radionuclide therapies (TRT) with immunotherapies is growing. External beam radiation therapy (EBRT) activates a type 1…”
Get full text

Frontispiece: Establishing Radiolanthanum Chemistry for Targeted Nuclear Medicine Applications by Aluicio‐Sarduy, Eduardo, Thiele, Nikki A., Martin, Kirsten E., Vaughn, Brett A., Devaraj, Justin, Olson, Aeli P., Barnhart, Todd E., Wilson, Justin J., Boros, Eszter, Engle, Jonathan W.

“…The image describes the radiochemical complexation of the novel radionuclides 132La and 135La for coupling with prostate cancer targeting moieties, with…”
Get full text

PET Imaging of the Neurotensin Targeting Peptide NOTA-NT-20.3 Using Cobalt-55, Copper-64 and Gallium-68 by Houson, Hailey A, Tekin, Volkan, Lin, Wilson, Aluicio-Sarduy, Eduardo, Engle, Jonathan W, Lapi, Suzanne E

“…Introduction: Neurotensin receptor 1 (NTSR1) is an emerging target for imaging and therapy of many types of cancer. Nuclear imaging of NTSR1 allows for…”
Get full text

86/90Y‑Labeled Monoclonal Antibody Targeting Tissue Factor for Pancreatic Cancer Theranostics by Ferreira, Carolina A, Ehlerding, Emily B, Rosenkrans, Zachary T, Jiang, Dawei, Sun, Tuanwei, Aluicio-Sarduy, Eduardo, Engle, Jonathan W, Ni, Dalong, Cai, Weibo

“…Pancreatic cancer is highly aggressive, with a median survival time of less than 6 months and a 5-year overall survival rate of around 7%. The poor prognosis…”
Get full text

Accelerator Production of Scandium Radioisotopes: Sc-43, Sc-44, and Sc-47 by Chernysheva, Margarita, Loveless, Shaun C, Brossard, Tom, Becker, Kaelyn, Cingoranelli, Shelbie, Aluicio-Sarduy, Eduardo, Song, Jeongseong, Ellison, Paul, Nolen, Jerry, Rotsch, David A, Lapi, Suzanne E, Engle, Jonathan W

“…Scandium radioisotopes are increasingly considered viable radiolabels for targeted molecular imaging (Sc-43, Sc-44) and therapy (Sc-47). Significant…”
Get more information

Sustainable production of radionuclidically pure antimony-119 by Olson, Aeli P., Verich, Francesca A., Ellison, Paul A., Aluicio-Sarduy, Eduardo, Nickles, Robert J., Mixdorf, Jason C., Barnhart, Todd E., Engle, Jonathan W.

“…Background Radiopharmaceutical therapy (RPT) uses radionuclides that decay via one of three therapeutically relevant decay modes (alpha, beta, and internal…”
Get full text